Longduoduo Co. Ltd.

11/16/2026 | Press release | Distributed by Public on 11/16/2026 16:28

Quarterly Report for Quarter Ending September 30, 2026 (Form 10-Q)

Management's Discussion and Analysis of Financial Condition and Results of Operations

Application of Critical Accounting Policies

The discussion and analysis of the Company's financial condition and results of operations is based upon its condensed consolidated financial statements, which have been prepared in accordance with United States generally accepted accounting principles. The preparation of these financial statements requires us to make significant estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. These items are monitored and analyzed by management for changes in facts and circumstances, and material changes in these estimates could occur in the future. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that we believe to be reasonable under the circumstances. Actual results may differ from our estimates if past experience or other assumptions do not turn out to be substantially accurate.

In connection with the preparation of our financial statements for the three months ended September 30, 2026, there was no accounting estimate made which was (a) subject to a high degree of uncertainty and (b) material to our results.

Results of Operations

Three Months Ended September 30, 2026 Compared to Three Months Ended September 30, 2025

The following table shows key components of the unaudited results of operations during the three months ended September 30, 2026 and 2025:

For the Three Months Ended
September 30,
2026 2025 Change
(Unaudited) (Unaudited) $ %
Total revenue $ 17,595 $ 658,764 $ (641,169 ) (97 )%
Cost of revenue - 6,710 (6,710 ) (100 )%
Gross Profit 17,595 652,054 (634,459 ) (97 )%
Total operating expenses 513,930 736,468 (222,538 ) (30 )%
Loss from operations (496,335 ) (84,414 ) (411,921 ) 488 %
Other income, net 17,490 40,326 (22,836 ) (57 )%
Loss before income taxes (478,845 ) (44,088 ) (434,757 ) 986 %
Income tax (benefit) expenses (4,678 ) 67,094 (71,772 ) (107 )%
Net loss $ (474,167 ) $ (111,182 ) $ (362,985 ) 326 %

During the three months ended September 30, 2026, we reported total revenue of $17,595 related to our agency services for Inner Mongolia Honghai Health Management Co., Ltd. ("Honghai"). In June of 2023, the Company began to engage in the sales agent business and focused on the sales of preventive healthcare & wellness solutions administered by Honghai, with whom we have a Sales Agency Agreement. As of September 30, 2026, we operate through five entities: Longduoduo Health Technology, Tianju, Qingguo, Rongbin and Chengheng, which are established in Huhhot, Ulanqab, Huhhot, Baotou and Ordos, respectively, which include four of the largest cities in Inner Mongolia, China.

Period to period revenue fell by 97% as compared with the operating revenue of $658,764 for the three months ended September 30, 2025. This decline was primarily attributable to the sales agent business. One important factor influencing revenue in the recent years is the impact of the economic environment. The prevailing economic environment, characterized by waning confidence in economic prospects, has compelled consumers to adopt significantly more cautious spending behavior, curtailing discretionary expenditures on preventive healthcare & wellness services and physical examinations. Management believes that the government has recently introduced policies to promote economic recovery, but it may take some time for the situation to truly improve. Meanwhile, as we wait for the economy to revive, the Company is implementing plans to improve its operations by adjusting its operational policies.

Furthermore, the Company is currently undergoing a strategic transition, with its core business gradually shifting towards gut microbiota-based products. However, sales momentum has slowed as the new product portfolio has yet to gain significant market traction, and market acceptance for the newly launched packages remains limited.

Cost of revenue relates solely to our healthcare service revenue, and mainly consists of our payments to the third-party healthcare service providers who perform healthcare services for our customers. During the three months ended September 30, 2026, the Company did not recognize any revenue or cost of revenue from principal arrangements. By comparison, our gross loss from service revenue for the three months ended September 30, 2025 was $1,104. As the total service revenue is minimal, profit turns negative due to fixed depreciation.

For the three months ended September 30, 2026, we achieved gross profit of $17,595. However, we realized a loss from operations of $496,335 for the three months ended September 30, 2026 because the Company incurred high fixed costs including staff costs and office expenses. Our operating expenses consist primarily of salaries and benefits, office expenses, professional fees and depreciation and amortization. Our operating expenses in the period ended September 30, 2026 decreased by $222,538, primarily attributable to:

● $86,717 in advertising and promotion expenses incurred in the three months ended September 30, 2026, compared to $314,481 recorded in the three months ended September 30, 2025. This decrease in advertising and promotion expenses is due to lower sales.
● $84,788 in professional fees in the three months ended September 30, 2026, compared to $93,254 recorded in the three months ended September 30, 2025. In both cases, the expense was primarily related to the costs incurred by the Company to establish and sustain its status as an SEC-reporting company in the United States.
● $138,763 in salaries and benefits expenses in the three months ended September 30, 2026, compared to $135,429 in the three months ended September 30, 2025.
● $151,279 in office expenses in the three months ended September 30, 2026, compared to $144,722 in the three months ended September 30, 2025. Office expenses mainly consist of entertainment expenses, business consulting fees, vehicle usage costs, social security contributions, travel expenses, and other office maintenance-related expenses.

Our net loss for the three months ended September 30, 2026 was $474,167, compared to a net loss of $111,182 in the three months ended September 30, 2025.

Our reporting currency is the U.S. dollar. Our functional currency is the local currency, which is the Renminbi (RMB) for our Chinese subsidiaries, the Hong Kong Dollar (HKD) for our Hong Kong subsidiaries, and the U.S. Dollar (USD) for our BVI subsidiary. Results of operations and cash flow for RMB and HKD are translated at average exchange rates during the period being reported upon, and assets and liabilities are translated at the unified exchange rate as quoted by OANDA on the balance sheet date. Translation adjustments resulting from this process are included in other comprehensive income (loss). For the three months ended September 30, 2026 and 2025, foreign currency translation adjustments of $21,149 and $13,886, respectively, have been reported as other comprehensive income in the consolidated statement of operations and comprehensive loss.

Liquidity and Capital Resources

As of September 30, 2026, the Company held $1,006,499 in cash and cash equivalents, yet working capital was only $85,068. This divergence primarily reflects our use of customer prepayments to fund operations. Of the $893,991 in deferred revenue recorded on the balance sheet as of September 30, 2026, the majority was utilized to cover ongoing operating expenses, leaving $209,375 in prepayments on the balance sheet. Going forward, we will strive to achieve a better balance of customer deposits and prepayments; but we will achieve that better balance only when profits from operations and funds from financing are adequate to support the expansion effort that will be necessary for successful operations.

Going Concern Consideration

In accordance with ASC 205-40, management has evaluated the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. As of September 30, 2026, the Company had cash and cash equivalents of $1,006,499, and reported a net loss of $474,167 and net cash used in operating activities of $615,031 for the three months then ended, primarily due to the material decline in commission revenue. Based on current projections, existing cash resources are insufficient to fund operations and satisfy obligations as they become due over the assessment period.

Management is pursuing remedial actions including new product expansion, further cost optimization, and potential financial support from the majority shareholder. The Company's ability to continue as a going concern depends on successful execution of these plans, generation of sufficient operating cash flows, and securing of additional financing, none of which can be assured. Accordingly, substantial doubt about the Company's ability to continue as a going concern exists.

Cash Flows

The following unaudited table summarizes our cash flows for the three months ended September 30, 2026 and 2025.

For the Three Months Ended
September 30,
2026 2025
(Unaudited) (Unaudited) Change
Net cash used in operating activities $ (615,031 ) $ (374,184 ) $ (240,847 )
Net cash used in investing activities - (29,948 ) 29,948
Effect of exchange rate fluctuation on cash and cash equivalents 32,600 8,707 23,893
Net decrease in cash and cash equivalents (582,431 ) (395,425 ) (187,006 )
Cash and cash equivalents, beginning of period 1,588,930 1,642,721 (53,791 )
Cash and cash equivalents, end of period $ 1,006,499 $ 1,247,296 $ (240,797 )

Net Cash Used in Operating Activities

For the three months ended September 30, 2026, operating activities used $615,031 in cash, compared with $374,184 of cash used in operating activities in the three months ended September 30, 2025. The net cash used in operating activities during the three months ended September 30, 2026, was primarily attributable to a net loss of $474,167, a cash outflow of $174,874 from the settlement of accounts payable, partially offset by a cash inflow of $92,617 from deferred revenue and a cash outflow of $70,187 from prepayments.

Net Cash Used in Investing Activities

Net cash used in investing activities for the three months ended September 30, 2026 was $nil, compared to $29,948 for the three months ended September 30, 2025. In the three months ended September 30, 2025, the cash was used for the purchase of fixed assets and office decoration.

Trends, Events and Uncertainties

The U.S. government, including the SEC, has made statements and taken actions that have led to changes in relations between the U.S. and China, and will impact companies with connections to the United States or China. Those actions by the U.S. government included imposing several rounds of tariffs affecting certain products manufactured in China and imposing sanctions and restrictions in relation to China. Actions by the SEC included issuing statements indicating that it would make enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new legislation, executive orders, tariffs, laws or regulations will be adopted, or the effect that any such actions would have on U.S.-domiciled companies with significant connections to China, our industry or on us. Any unfavorable government policies on cross-border relations, including increased scrutiny on companies with significant China-based operations, capital controls or tariffs, may affect our ability to raise capital and the market price of our shares. If any new legislation, executive orders, tariffs, laws and/or regulations are implemented, if existing trade agreements are renegotiated or if the U.S. or Chinese governments take retaliatory actions due to the recent U.S.-China tensions, such changes could have an adverse effect on our business, financial condition and results of operations, our ability to raise capital and the market price of our shares. Changes in United States and China relations and/or regulations may adversely impact our business, our operating results, our ability to raise capital and the market price of our shares.

Other than the factors listed above we do not know of any trends, events or uncertainties that have had or are reasonably expected to have a material impact on our net sales or revenues or income from continuing operations.

Recent Accounting Pronouncements

There were no recent accounting pronouncements that we expect to have a material effect on the Company's financial position or results of operations.

Longduoduo Co. Ltd. published this content on November 16, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on November 16, 2026 at 22:28 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]